Clinical outcomes for immune checkpoint inhibitors plus chemotherapy in non-small-cell lung cancer patients with uncommon driver gene alterations | BMC Cancer
Upvotes: 1
Favorite this post:
Mark as read:
Your rating:
Add this post to a custom list